tert-butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate
|
- $555 - $1472
- Product name: tert-butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate
- CAS: 1429309-49-8
- MF: C20H27N5O4
- MW: 401.46
- EINECS:
- MDL Number:MFCD22690752
- Synonyms:tert-butyl 4-[4-(4-ethoxycarbonylpyrazol-1-yl)-2-pyridyl]piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[4-[4-(ethoxycarbonyl)-1H-pyrazol-1-yl]-2-pyridinyl]-, 1,1-dimethylethyl ester
8 prices
Selected condition：
Brand
- Abosyn
- Alichem
- Chemenu
- Crysdot
- Matrix Scientific
- SynQuest Laboratories
Package
- 250mg
- 0.25g
- 500mg
- 1g
- ManufacturerAbosyn
- Product number21-1529
- Product descriptiontert-butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 95%-98%
- Packaging0.25g
- Price$820
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1429309498
- Product descriptiontert-Butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate
- Packaging1g
- Price$646.8
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM169425
- Product descriptiontert-Butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 95%
- Packaging1g
- Price$767
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11258187
- Product descriptiontert-Butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 95+%
- Packaging1g
- Price$820
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101652
- Product descriptiontert-Butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 94%
- Packaging250mg
- Price$555
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101652
- Product descriptiontert-Butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 94%
- Packaging500mg
- Price$887
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101652
- Product descriptiontert-Butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 94%
- Packaging1g
- Price$1420
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H58-1-8K
- Product descriptiontert-Butyl 4-{4-[4-(ethoxycarbonyl)-1H-pyrazol-1-yl]pyridin-2-yl}piperazine-1-carboxylate
- Packaging1g
- Price$1472
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Abosyn | 21-1529 | tert-butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 95%-98% | 0.25g | $820 | 2021-12-16 | Buy |
| Alichem | 1429309498 | tert-Butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate | 1g | $646.8 | 2021-12-16 | Buy |
| Chemenu | CM169425 | tert-Butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 95% | 1g | $767 | 2021-12-16 | Buy |
| Crysdot | CD11258187 | tert-Butyl4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 95+% | 1g | $820 | 2021-12-16 | Buy |
| Matrix Scientific | 101652 | tert-Butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 94% | 250mg | $555 | 2021-12-16 | Buy |
| Matrix Scientific | 101652 | tert-Butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 94% | 500mg | $887 | 2021-12-16 | Buy |
| Matrix Scientific | 101652 | tert-Butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate 94% | 1g | $1420 | 2021-12-16 | Buy |
| SynQuest Laboratories | 4H58-1-8K | tert-Butyl 4-{4-[4-(ethoxycarbonyl)-1H-pyrazol-1-yl]pyridin-2-yl}piperazine-1-carboxylate | 1g | $1472 | 2021-12-16 | Buy |
Properties
Boiling point :567.1±50.0 °C(Predicted)
Density :1.25±0.1 g/cm3(Predicted)
pka :5.89±0.28(Predicted)
Density :1.25±0.1 g/cm3(Predicted)
pka :5.89±0.28(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|